The organization argues that designating pharmacists as providers under Medicare Part B would have allowed Congress to dramatically expand COVID-19 testing and immunization efforts.
“The final coronavirus stimulus legislation during this election year presents our shining opportunity to achieve a targeted version of provider status. Together with our members, APhA wants to unleash the full potential of pharmacists’ contributions for testing and immunization during COVID-19,” APhA CEO Scott Knoer, PharmD, said.
APhA created a petition urging Congress to include provider status for pharmacists in its next legislative package.
More articles on pharmacy:
Trump’s meeting with pharma execs canceled after drug lobbies refuse to show up
AstraZeneca to pay Emergent $174M to expand production of COVID-19 vaccine candidate
Generic drug trade group loses bid to block California pay-to-delay law
